Neurocrine Biosciences (0K6R.L) Stock Price
$130.3 1.4%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
7 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Neurocrine Biosciences, AI stock picks, stock alerts and much more.
0K6R.L AI Stock Analysis
Financial Performance
Neurocrine Biosciences' reported revenue of $572.6M last quarter, a decrease of -8.8% from the previous quarter and -3% year over year. The gross profit was $563.4M, also down by -8.9% from the previous quarter and -1.9% YoY. Their operating income profit significantly decreased to $23.6M, down by -83.4% from the previous quarter and a substantial drop of -84% YoY. The EBITDA ratio stood at 0.04 indicating low profitability.
Stock Price
The stock is currently trading at $126.6, up by 6% in the last month but down by -8.1% YoY which shows some volatility in its performance over time periods considered here.The Relative Strength Index (RSI) value is currently at 59.24 suggesting that it's neither oversold nor overbought while its 200-day moving average stands at $114 indicating an upward trend in recent times.
Alternative Data Signals
The company's web traffic indicates an estimated monthly visitor count of around 18598 which is up by +2%, however, it has seen a decline of -19.4% on a yearly basis which might be concerning.Neurocrine Biosciences has been showing signs of contraction with current job openings standing at only 81 positions (-3.6 MoM and-19.% YoY). This could indicate potential cost-cutting measures or slow growth prospects.On employee business outlook, about 81% report positive sentiments which are encouraging for investors.In terms of social media presence and engagement, Neurocrine Biosciences has been growing with Twitter followers up by 14.4% and Facebook followers up by a significant 60.1% in the last three months.
Conclusion
While there have been some negative indicators such as declining revenue, gross profit and operating income, positive signs are observed in the stock price trend, employee business outlook and increasing social media presence. The analysis for Neurocrine Biosciences' stock is neutral to slightly bullish.
Note: This AI Stock Analysis is based on data as of June 28. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Neurocrine Biosciences (0K6R.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $130.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0K6R.L
-
Neurocrine Biosciences, Inc.
-
Symbol
0K6R.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
12.9B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$454.2 1.4% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$7.12 6.7% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.98 5.5% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$11.48 0.2% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$1.1 9.5% |
5 |
News
0K6R.L Alternative Data
Web Traffic
Neurocrine Biosciences receives an estimated 18598 monthly visitors to neurocrine.com.
-
Web Traffic
18598
-
Change from Previous Month
2%
-
3 Month Change
19.7%
-
YoY Change
19.7%
Twitter Followers
Neurocrine Biosciences has 764 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.3% over the last month.
-
Twitter Followers
764
-
Daily Change
0%
-
1 Month Change
2.3%
-
3 Month Change
7.8%
-
YoY Change
7.8%
Facebook Engagement
Neurocrine Biosciences has engaged 21 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
21
-
Daily Change
16.7%
-
1 Month Change
32.3%
-
3 Month Change
425%
-
YoY Change
425%
Job Postings
Neurocrine Biosciences has an estimated 81 open job postings, which is down -8% over the last month.
-
Job Postings
81
-
Daily Change
2.5%
-
1 Month Change
8%
-
3 Month Change
13.8%
Reddit Mentions
Neurocrine Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
74,659 are following Neurocrine Biosciences on LinkedIn, up by 2.1% over the last month.
-
LinkedIn Followers
74659
-
Daily Change
2.1%
-
1 Month Change
2.1%
-
3 Month Change
5.5%
Business Outlook
According to employee reviews, the business outlook among employees at Neurocrine Biosciences is 81 out of 100 (very bullish).
-
Business Outlook
81
-
Change from Previous Month
0%
-
3 Month Change
6.9%
-
YoY Change
6.9%
LinkedIn Employees
According to LinkedIn, Neurocrine Biosciences has 1,930 employees, up by 1.8% over the last month.
-
LinkedIn Employees
1930
-
Daily Change
1.8%
-
1 Month Change
1.8%
-
3 Month Change
3.9%
-
YoY Change
3.9%
News Mentions
Neurocrine Biosciences was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
50%
-
YoY Change
50%
App Downloads
-
App Downloads
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0K6R.L Financials
0K6R.L Key Metrics
-
Total Revenue
$572.6M
-
Net Income
$7.9M
-
Earnings per Share
$0.08
-
Free cash flow
$54.1M
-
EBITDA
$23.6M
-
EBITDA Ratio
0.0412155
-
Total Assets
$3.7B
0K6R.L 2-year Revenue & Income
0K6R.L 2-year Free Cash Flow
0K6R.L Technicals
0K6R.L SMA
0K6R.L RSI
FAQ
What's the current price of Neurocrine Biosciences (0K6R.L) Stock?
The price of an Neurocrine Biosciences (0K6R.L) share is $130.3.
What's the market cap of Neurocrine Biosciences?
The current market cap of Neurocrine Biosciences is 12.9B.
Should I buy or sell 0K6R.L?
Multiple alternative data signals suggest that Neurocrine Biosciences stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Neurocrine Biosciences a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Neurocrine Biosciences stock. The bullish indicators suggest that Neurocrine Biosciences' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Neurocrine Biosciences (0K6R.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Neurocrine Biosciences stock, given the bullish outlook.
What are some stocks similar to Neurocrine Biosciences (0K6R.L) that investors often compare it to?
Neurocrine Biosciences (0K6R.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Emergent BioSolutions Inc., Abeona Therapeutics Inc., Walgreens Boots Alliance and Esperion Therapeutics.
What is the forecast for Neurocrine Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Neurocrine Biosciences' stock price to be around $140.9 in 2026. Starting from the current price of $130.3, this represents a 8.1% change in price, indicating a bullish outlook for the stock.
How to buy Neurocrine Biosciences (0K6R.L) Stock?
Neurocrine Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Neurocrine Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.